StonvexLoading…
StonvexStonvexStonvexCore line items from NRDE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $2.34M | $2.34M |
Operating Income | $-9.47M | $-8.95M | $-348.90M | $-345.29M |
Net Income | $-6.66M | $-7.00M | $-343.07M | $-342.72M |
EPS (Diluted) | $-0.54 | $-0.52 | $-21.67 | $-21.38 |
Total Assets | $58.25M | $63.71M | $92.17M | $107.97M |
Total Liabilities | $15.25M | $21.09M | $45.87M | $62.17M |
Cash & Equivalents | $26.10M | $20.94M | $87.10M | $93.65M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-147.32M | $-130.16M |
Shares Outstanding | 16.10M | 16.10M | 15.95M | 15.95M |